Zinc Acetate
Various Alimentary Tract and Metabolism Products
Sold as Xcellderma · Equate Calaspray · Shopko Anti-Itch · Savvy Itch Stopping · Westlake Itch Relief
- Drug class
- Various Alimentary Tract and Metabolism Products
- Availability
- Over-the-counter
- Routes
- Topical
- Markets covered
- 3
- Products on record
- 32
- FDA reports (12 mo)
- 162
Overview
Zinc Acetate is an active pharmaceutical ingredient in the Various Alimentary Tract and Metabolism Products group (A16AX). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 13 | February 27, 2026 |
| GB United Kingdom | MHRA | 11 | April 17, 2026 |
| CA Canada | Health Canada | 8 | April 14, 2026 |
USUnited States· FDA
13 products
Uses
Uses ■ temporarily relieves pain and itching associated with ■ insect bites ■ minor burns ■ sunburn ■ minor skin irritations ■ minor cuts ■ scrapes ■ rashes due to poison ivy, poison oak, and poison sumac ■ dries the oozing and weeping of poison ivy, poison oak, and poison sumac
How to take
GBUnited Kingdom· MHRA
11 products
Uses
Zineryt is indicated in children, adults and the elderly. It is used as topical treatment of acne vulgaris.
How to take
CACanada· Health Canada
8 products
8 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [3].
Drug interactions
Known interactions involving Zinc Acetate. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 05ee2662-6a51-6e… · revised December 19, 2024 [PDF]
- [2]MHRA (UK) · PL450430097 · revised April 17, 2026
- [3]Health Canada (DPD) · 02246156 · revised March 28, 2026
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.